The Latest Cardiac and Vascular News
Feb. 14, 2018 13:00 UTC 50 Premier U.S. Centers Adopt Sentinel Device in First Phase of Commercial Launch More Than 5,500 Patients Protected Worldwide Only Commercially Available TAVR Cerebral Protection Device in U.S., Europe and Asia Stacy Enxing Seng Joins Company’s Board of Directors SANTA ROSA, Calif.–(BUSINESS WIRE)– Since FDA […]
Abiomed Receives Approval for Expanded FDA Indication for High Risk Percutaneous Coronary Intervention (PCI) Procedures DANVERS, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) — Abiomed(Nasdaq:ABMD), a leading provider of breakthrough heart support and recovery technologies, today announced that it has received an expanded U.S. Food and Drug Administration (FDA) Pre-Market Approval (PMA) for the […]
VANCOUVER, BRITISH COLUMBIA — (Marketwired) — Feb 14, 2018 — Novoheart(“Novoheart” or the “Company”) (TSX VENTURE: NVH), through its wholly owned US subsidiary, has entered into a commercial agreement with Sumocor LLC(“Sumocor”), a biotech company based in New York City that is focused on the development of therapeutics for cardiovascular diseases. Pursuant to […]
Topline Results from First-in-Human Phase 1 Study of MYK-491 in Healthy Volunteers Demonstrated Tolerability and Increased Contractility SOUTH SAN FRANCISCO, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) —MyoKardia (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, today announced that dosing has commenced in […]
DUBLIN–(BUSINESS WIRE)–The “Global Heart Valve Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025” report has been added to ResearchAndMarkets.com’s offering. The global heart valve devices market was valued at US$ 4,945 Mn in 2016, and is expected to reach US$ 13,377.9 Mn […]
VANCOUVER, Feb. 12, 2018 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that Fred Colen, President and Chief Executive Officer of Neovasc, is scheduled to present at the LEERINK Partners 7th Annual Global Healthcare Conference on Wednesday, February 14th at 2:30 pm ET at the Lotte New York Palace in New York City. A live […]
JenaValve raises $5m FEBRUARY 6, 2018 BY FINK DENSFORD of MassDevice As first reported by Fink Densford of MassDevice: JenaValve Technology has raised $4.9 million in a new round of debt financing, according to an SEC filing posted this week. The Irvine, Calif.-based company is one of several smaller players looking to enter the […]
Feb. 2, 2018 14:00 UTC IRVINE, Calif.–(BUSINESS WIRE)– JenaValve Technology, Inc., a developer, manufacturer and marketer of differentiated transcatheter aortic valve replacement (TAVR) systems for the treatment of aortic valve disease, today announced the appointment of veteran medical device executive Laura A. Brenton as Vice President of Clinical and International Market […]
First Patient Treated by Dr. Shigeru Saito at Shonan Kamakura General Hospital ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that it has commercially treated the first patient in […]
Procyrion Raises $16 Million Series C for Clinical Trials of Its Breakthrough Aortix Heart Pump Houston, TX (January 30, 2018) – Procyrion, Inc., a clinical-stage medical device company, today announced the completion of a $16 million Series C funding round led by an affiliate of Fannin Partners. Returning investors include […]
